Novelix Pharmaceuticals Limited (BOM:536565)
India flag India · Delayed Price · Currency is INR
69.00
-1.05 (-1.50%)
At close: Nov 16, 2026

Novelix Pharmaceuticals Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
1,5521,323307.1942.2414.0586.09
Other Revenue
0.010.320.153.075.163.04
1,5521,323307.3345.3119.289.13
Revenue Growth
82.85%330.60%578.26%135.96%-78.45%-7.01%
Cost of Revenue
1,4691,269295.938.4513.8382.94
Gross Profit
83.1254.7811.436.865.386.18
Selling, General & Admin
8.37.521.321.883.565.79
Other Operating Expenses
14.3811.948.512.841.843.61
Operating Expenses
25.4420.4810.216.485.9611
Operating Income
57.6934.31.220.38-0.58-4.82
Interest Expense
-2.68-0.23----0.58
Interest & Investment Income
--0.01---
Earnings From Equity Investments
-----0.87
Currency Exchange Gain (Loss)
-0.03-0.03----
Other Non Operating Income (Expenses)
---00-
EBT Excluding Unusual Items
54.9734.041.230.38-0.58-4.53
Gain (Loss) on Sale of Investments
------15.6
Gain (Loss) on Sale of Assets
----0.17--0.23
Pretax Income
54.9734.041.230.21-0.58-20.35
Income Tax Expense
8.398.480.390.110.01-0.08
Earnings From Continuing Operations
46.5825.570.850.1-0.6-20.27
Net Income
46.5825.570.850.1-0.6-20.27
Net Income to Common
46.5825.570.850.1-0.6-20.27
Net Income Growth
390.76%2925.56%711.56%---
Shares Outstanding (Basic)
2821101088
Shares Outstanding (Diluted)
2821101088
Shares Change
124.52%111.91%-4.44%28.54%--
EPS (Basic)
1.661.210.080.01-0.07-2.50
EPS (Diluted)
1.661.210.080.01-0.07-2.50
EPS Growth
118.59%1327.77%749.24%---

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-361.77-256.45-137.91-3.43-24.1-2.12
Free Cash Flow Per Share
-12.88-12.16-13.86-0.33-2.98-0.26
Gross Margin
5.35%4.14%3.72%15.14%27.99%6.94%
Operating Margin
3.72%2.59%0.40%0.85%-3.04%-5.41%
Profit Margin
3.00%1.93%0.27%0.23%-3.12%-22.74%
Free Cash Flow Margin
-23.30%-19.38%-44.87%-7.58%-125.49%-2.38%
EBITDA
60.435.281.60.77-0.02-4.02
EBITDA Margin
3.89%2.67%0.52%1.69%-0.12%-4.51%
D&A For EBITDA
2.710.980.380.380.560.8
EBIT
57.6934.31.220.38-0.58-4.82
EBIT Margin
3.72%2.59%0.40%0.85%-3.04%-5.41%
Effective Tax Rate
15.26%24.90%31.47%51.02%--
Revenue as Reported
1,5521,323307.3445.3119.291.63
Advertising Expenses
-0.110.160.220.270.38